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OBJECTIVES The aim of this study was to assess the prevalence and risk factors for coronary artery disease
(CAD) in a native urban South Indian population.
BACKGROUND High prevalence rates of premature CAD have been reported in migrant Asian Indians.
There are very few studies on CAD in native Indians living in the Indian subcontinent.
METHODS The Chennai Urban Population Study (CUPS) is an epidemiological study involving two
residential areas in Chennai in South India. Of the total of 1,399 eligible subjects (age $20
years), 1,262 (90.2%) participated in the study. All the study subjects underwent a glucose
tolerance test and were categorized as having normal glucose tolerance (NGT), impaired
glucose tolerance (IGT) or diabetes. Twelve-lead electrocardiogram (ECG) was performed in
1,175 individuals (84%). Coronary artery disease was diagnosed based on previous medical
history or Minnesota coding of ECGs.
RESULTS The overall prevalence rate of CAD is 11.0% (age standardized, 9.0%). The prevalence rates
of CAD were 9.1%, 14.9% and 21.4% in those with NGT, IGT and diabetes, respectively.
Prevalence of CAD increased with an increase in total cholesterol (trend chi-square: 26.2, p ,
0.001), low-density lipoprotein (LDL) cholesterol (trend chi-square: 24.5, p , 0.001),
triglycerides (trend chi-square: 9.96, p 5 0.002) and total cholesterol/high-density lipopro-
tein ratio (trend chi-square: 6.14, p 5 0.0132). Multiple logistic regression analysis identified
age (odds ratio [OR]: 1.05, p , 0.001) and LDL cholesterol (OR: 1.009, p 5 0.051) as the
risk factors for CAD.
CONCLUSIONS The prevalence of CAD is rising rapidly in urban India. Lifestyle changes and aggressive
control of risk factors are urgently needed to reverse this trend. (J Am Coll Cardiol 2001;38:
682–7) © 2001 by the American College of Cardiology
Asian Indians have considerably higher prevalence of pre-
mature coronary artery disease (CAD) and standardized
mortality rates for CAD compared with Europeans, Chi-
nese and Malays (1–4). A recent report from the Study of
Health Assessment and Risk in Ethnic Groups (SHARE)
indicates a significantly higher risk of cardiovascular events
among South Asians compared with Europeans and Chi-
nese (3). Within the Indian subcontinent, a dramatic
increase in the prevalence of CAD has been predicted in the
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next 20 years due to rapid changes in demography and
lifestyle consequent to economic development (5,6). Earlier
studies in Asian Indians have shown that classical risk
factors do not explain the excess of CAD seen in this ethnic
group (7–13). It is also possible that the risk factors for
CAD could differ considerably between native and migrant
Indians because of differences in diet, physical activity, body
weight and lifestyle changes consequent to affluence and
cultural changes consequent to migration. Studies on the
prevalence and risk factors of CAD in native Indians within
the subcontinent are, therefore, urgently needed, particu-
larly since the population of India has just reached one
billion. In this paper, we report on the prevalence of CAD
in an urban South Indian population and look at its
relationship with serum lipids.
METHODS
The Chennai Urban Population Study (CUPS) is an ongo-
ing population based study on diabetes and its complications
in Chennai (formerly Madras) in Southern India, a city with
a population of approximately six million people. This study
was approved by the institutional ethical committee. The
methodological details of the study have been published
recently (14). Briefly, two residential colonies in the urban
Chennai city were selected for the study. All individuals age
$20 years were eligible for the study. Of the total 1,399
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individuals, 1,262 (response rate 90.1%) underwent a
screening program for diabetes, hypertension and other
components of the insulin resistance syndrome (metabolic
syndrome). Informed consent was obtained from all the
participants. Ninety-one individuals had diabetes before the
survey, and 61 were detected to have diabetes after the
survey, and thus, there were a total of 152 diabetic subjects
living in the two colonies. Additionally, 74 subjects with
impaired glucose tolerance (IGT) were also identified based
on the World Health Organization consultation group
criteria (15).
Anthropometric measurements included height and
weight measurements, and the body mass index (BMI) was
calculated using the formula weight (kg)/height (m2). Waist
and hip were measured using standard techniques, and the
mean of two measurements was taken for calculating the
waist-hip ratio (WHR). The weight/height ratio was also
calculated. Individuals were classified as nonsmokers (never
smoked) and smokers (ex-smokers plus current smokers).
Alcohol intake was categorized as nil and yes (social
drinking and regular drinking). Blood pressure (BP) was
recorded in the sitting position in the right arm with a
mercury sphygmomanometer (Diamond Deluxe BP appa-
ratus, Pune, India). Two readings were taken 5 min apart,
and the mean of the two was taken as the BP. Blood
pressure was recorded by a trained physician who was
unaware of the clinical status of the study subjects. Systolic
pressure was recorded at the first appearance of sounds, and
diastolic pressure was measured at the disappearance of
sounds.
A fasting blood sample was collected after an overnight
fast of at least 10 h for biochemical investigations. All
biochemical parameters were carried out on Corning Ex-
press Plus Auto Analyser (Corning, Medfield, Massachu-
setts) using kits supplied by Boehringer Mannheim, Ger-
many. Fasting and 2-h plasma glucose estimations (glucose
oxidase method), serum cholesterol (CHOD-PAP method)
and serum triglycerides (GPO-PAP method) were mea-
sured. High-density lipoprotein (HDL) cholesterol was
estimated by CHOD-PAP method after precipitating low-
density lipoprotein (LDL) and chylomicron fractions by the
addition of phosphotungstic acid in the presence of mag-
nesium ions and very low-density lipoprotein. Low-density
lipoprotein cholesterol was calculated using the Friedewald
formula (16). Hypertension was diagnosed based on a past
medical history or if the BP was . 140/90 mm Hg (17).
CAD. A resting 12-lead electrocardiogram (ECG) was
carried out on 1,175 subjects (response rate: 84%). Minne-
sota coding was used to grade the ECGs by a single trained
grader (G. P.) who was blinded to the clinical status of the
patient.
Definition of CAD for prevalence studies. Coronary
artery disease was diagnosed based on a past history of
documented myocardial infarction (MI) or ECG changes
suggestive of ST-segment depression (Minnesota codes
1-1-1 to 1-1-7) or Q-wave changes (Minnesota codes 4-1
to 4-2) or T-wave changes (Minnesota codes 5-1 to 5-3)
(15). Documented MI was diagnosed if an individual had a
positive history of MI in the medical records (a summary
report after discharge from a hospital). Medical records were
verified wherever possible, and drug treatment for CAD
(aspirin or nitrates) was also diagnosed as CAD.
Definition of CAD for analysis of risk factors. For
analysis of cardiovascular risk factors, CAD was diagnosed
based on documented MI or the presence of Q-waves or
ST-segment changes on ECG.
Statistical analysis. All the data were computed on FoxPro
database, and statistical analyses were done using SPSS
PC 1 4.0.1 version. The crude prevalence rates obtained
from the study were age-adjusted based on the 1991
Chennai population census. Student t tests were used for
comparison of means, and chi-square tests and Fisher exact
tests were used for comparison of frequencies. Univariate
regression analysis was performed using CAD as a depen-
dent variable and age, gender, BMI, WHR, total, LDL and
HDL cholesterol, triglycerides, systolic and diastolic BP,
fasting and 2-h plasma glucose and pack years of smoking as
independent variables. The independent variables that had a
p value ,0.2 on univariate analysis were used for risk factor
analysis in multiple logistic regression analysis.
RESULTS
Table 1 shows the prevalence of CAD in the population.
The overall prevalence of CAD is 11%, while the age
standardized prevalence is 9.0%. The prevalence of Q-wave
changes and ST-segment depression are similar among men
and women, while the prevalence of T-wave abnormalities
is higher among women (p , 0.001). The age standardized
prevalence rate of overall Q-wave abnormalities among men
is 2.1%, while in women it is 1.3%. The prevalence of CAD
is also higher in those with IGT and diabetes compared
with the normal glucose tolerance group.
It is possible that subjects with T-wave changes (Minne-
sota codes 5-1 to 5-3) may not have CAD but could have
Abbreviations and Acronyms
ACE 5 angiotensin-converting enzyme
BMI 5 body mass index
BP 5 blood pressure
CAD 5 coronary artery disease
CUPS 5 Chennai Urban Population Study
ECG 5 electrocardiogram or electrocardiography
HDL 5 high-density lipoprotein
IGT 5 impaired glucose tolerance
LDL 5 low-density lipoprotein
MI 5 myocardial infarction
OR 5 odds ratio
SHARE 5 Study of Health Assessment and Risk in
Ethnic Groups
UKPDS 5 United Kingdom Prospective Diabetes Study
WHR 5 waist-hip ratio
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left ventricular hypertrophy or other nonspecific causes.
Hence, for the rest of the paper, to look at risk factors for
CAD, only those with documented MI or those who had
Q-wave or ST-segment changes were included (n 5 47).
The group with CAD was older than the group without
CAD (p , 0.001). Body mass index (p 5 0.006), waist
circumference (p 5 0.039), waist-to-height ratio (p 5
0.012), systolic and diastolic BP (p 5 0.02) and hyperten-
sion (p , 0.001) were higher among the group with CAD
compared with the group without CAD (p , 0.05)
(Table 2).
Of the 11 CAD subjects who were receiving antihyper-
tensive therapy, six were receiving beta-adrenergic blocking
agents alone; two were receiving angiotensin-converting
enzyme (ACE) inhibitors; one was receiving a calcium
channel blocking agent, and two subjects were receiving a
combination therapy of beta-blockers and ACE inhibitors.
Among the 41 subjects who were receiving antihypertensive
therapy in the non-CAD group, 14 were receiving beta-
blockers; 12 were receiving calcium channel blockers; seven
were receiving alpha receptor agonists; two were receiving
ACE inhibitors, and six subjects were receiving a combina-
tion of beta-blockers and calcium channel blockers.
Only one subject in the CAD group (statin) and six
subjects in the non-CAD group (3: statins, 3: fibrates) were
receiving lipid lowering drugs.
The prevalence of CAD is 1.4% in subjects with choles-
terol #4.0 mmol/l (154 mg/dl), 3.3% in those with cho-
lesterol between 4.01 to 5 mmol/l (155 to 192 mg/dl), 6.9%
in those between 5.01 mmol/l to 6.0 mmol/l (193 to 231
mg/dl), 11.3% in the 6.01 to 7.0 mmol/l group (232 to 269
mg/dl) and 12.5% in subjects with cholesterol levels .7.0
mmol/l (269 mg/dl). This increase is statistically significant
(trend chi-square: 26.2, p , 0.001).
The prevalence of CAD in subjects with triglycerides
#1 mmol/l (88 mg/dl) is 2.1%, 4.8% for triglycerides 1.01
to 2.0 mmol/l (89 to 177 mg/dl), 6.3% for those between
2.01 and 3.0 mmol/l (178 to 265 mg/dl) and 9.0% for those
with triglycerides .3.0 (265 mg/dl). This increase is statis-
tically significant (trend chi-square: 9.96, p 5 0.002).
The prevalence of CAD is 7.6% in individuals with HDL
cholesterol lower than 0.7 mmol/l (27 mg/dl), 2.5% in those
between 0.71 and 0.90 mmol/l (28 to 35 mg/dl), 3.9% in
those between 0.91 to 1.1 mmol/l (36 to 42 mg/dl), 6.1% for
1.11 to 1.3 mmol/l group (43 to 50 mg/dl) and 4.3% for
those with HDL cholesterol for .1.3 mmol/l (50 mg/dl)
(trend chi-square: 0.10, p 5 NS).
The prevalence of CAD is 2.2% in subjects with LDL
cholesterol #3.0, 5.4% for LDL cholesterol between 3.01 to
4.0, 11.5% for LDL cholesterol between 4.01 to 5.0 and
11.8% for LDL cholesterol .5.0. There is a significant
increase in the prevalence of CAD with an increase in LDL
cholesterol levels (trend chi-square: 24.5, p , 0.0001).
The prevalence of CAD is 2.6% in subjects with total
cholesterol to HDL ratio #3.5, 2.4% for a ratio between 3.5
and 4.5, and 5.9% for a ratio $5.5. The increase in the
prevalence of CAD with an increase in total cholesterol to
Table 1. Prevalence of CAD in the Study Population
Total Population Glucose Tolerance
Total
(n 5 1,175)
Men
(n 5 518)
Women
(n 5 657)
NGT
(n 5 956)
IGT
(n 5 74)
DM
(n 5 145)
Documented MI, n (%) 14 (1.2%) 7 (1.4%) 7 (1.1%) 9 (0.9%) — 5 (3.4%)†
Q-wave changes alone (without past MI), n (%) 15 (1.3%) 7 (1.4%) 8 (1.2%) 5 (0.5%) 1 (1.4%) 9 (6.2%)‡
Overall Q waves, n (%) 25 (2.1%) 14 (2.7%) 11 (1.6%) 12 (1.2%) 1 (1.4%) 12 (8.2%)‡
ST-segment depression, n (%) 18 (1.5%) 8 (1.5%) 10 (1.5%) 10 (1.1%) 4 (5.4%)§ 4 (2.8%)
T-wave abnormalities, n (%) 82 (7.0%) 10 (1.9%) 72 (11.0%)* 63 (6.6%) 6 (8.1%) 13 (9.0%)
Total CAD prevalence, n (%) 129 (11.0%) 32 (6.2%) 97 (14.8%)* 87 (9.1%) 11 (14.9%) 31 (21.4%)‡
Age standardized CAD prevalence 9.0% 5.0% 12.4%* — — —
*p , 0.001, compared with men; †p 5 0.03, versus NGT; ‡p , 0.001, versus NGT; §p 5 0.009, versus NGT.
CAD 5 coronary artery disease; DM 5 diabetes mellitus; IGT 5 impaired glucose tolerance; MI 5 myocardial infarction; NGT 5 normal glucose tolerance.
Table 2. Clinical and Biochemical Characteristics of the
Study Population
Parameters
With CAD
(n 5 47)
Without CAD
(n 5 1,128) p Value
Age (yr) 58 6 12 42 6 11 , 0.0001
Men, n (%) 22 (47%) 496 (44%) NS
BMI (kg/m2) 24.0 6 3.7 22.4 6 4.5 0.006
Waist circumference (cm) 80.2 6 14.4 76 6 13 0.039
Waist-hip ratio 0.86 6 0.08 0.84 6 0.09 NS
Waist-to-height ratio 0.52 6 0.09 0.49 6 0.08 0.012
Systolic BP (mm Hg) 131 6 19 122 6 16 0.002
Diastolic BP (mm Hg) 83 6 12 79 6 10 0.029
Exsmokers, n (%) 2 (4.3%) 32 (2.8%) NS
Current smokers, n (%) 3 (6.4%) 156 (13.8%) NS
Pack years of smoking 46.4 6 22.9 22.9 6 28.6 0.070
Alcohol, n (%) 11 (23.4%) 279 (24.7%) NS
Hypertension, n (%) 20 (43%) 145 (13%) , 0.0001
Fasting plasma glucose
(mmol/l)
5.8 6 3.0 4.8 6 2.3 0.021
2-h post plasma glucose
(mmol/l)
9.5 6 5.4 6.7 6 4.2 0.001
Serum cholesterol (mmol/l) 5.28 6 0.99 4.46 6 1.0 , 0.0001
Serum triglycerides (mmol/l) 1.58 6 0.67 1.34 6 0.83 0.021
HDL cholesterol (mmol/l) 1.06 6 0.25 1.03 6 0.26 NS
LDL cholesterol (mmol/l) 3.49 6 0.86 2.81 6 0.88 , 0.0001
Total cholesterol/HDL ratio 5.2 6 1.3 4.5 6 1.31 0.0006
LDL/HDL ratio 3.4 6 1.0 2.9 6 1.1 0.0022
Hypertensive drugs, n (%) 11 (23.4%) 41 (3.6%) , 0.0001
Lipid lowering drugs, n (%) 1 (2.1%) 6 (0.5%) —
BMI 5 body mass index; BP 5 blood pressure; CAD 5 coronary artery disease;
HDL 5 high-density lipoprotein; LDL 5 low-density lipoprotein.
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HDL ratio is statistically significant (trend chi-square: 6.14,
p 5 0.013).
Multiple logistic regression analysis was performed using
CAD as the dependent variable and the risk factors, which
had a significant association with CAD in the univariate
analysis, namely age, BMI, systolic and diastolic BP, HDL
and LDL cholesterol, triglycerides and fasting plasma glu-
cose, as the independent variables. Only age (odds ratio
[OR]: 1.05, p , 0.001) and LDL cholesterol (OR: 1.009,
p 5 0.051) had a significant association with CAD (Table 3).
DISCUSSION
Prevalence of CAD. Earlier studies on Asian Indians,
mostly in migrant populations, have reported on the high
prevalence of CAD and its occurrence at a young age
(premature CAD) (1,3,12). This paper reports on the
prevalence of CAD in an urban South Indian population
and shows that the prevalence of CAD in urban Indians is
now approaching the figures reported in migrant Indians,
which range between 7% to 17% (18–22). The overall figure
of 11% of CAD in the population represents approximately
a 10-fold increase in the prevalence of CAD in urban India
during the last 40 years (23–27).
Bhatnagar et al. (12) compared migrant Indians living in
West London with native Indians living in Punjab. The
migrant Indians had higher BMI, systolic BP and signifi-
cantly higher lipid levels. However, both the migrant and
native Indians had elevated lipoprotein(a) levels, suggesting
that genetic influences may predispose Indians to premature
CAD (3,11,28). It is of interest that, in the SHARE study,
while atherosclerosis (carotid intimal medial thickness) was
actually higher among Europeans, thrombosis was signifi-
cantly higher in South Asians, suggesting that a thrombo-
genic risk factor profile predisposes the latter group to CAD
(3).
Risk factors for CAD. Total and LDL cholesterol are
considered to be important risk factors for CAD (29,30) in
some studies, while hypertriglyceridemia is reported to be
the major risk factor in others (31,32). Other reports show
that microalbuminuria (33), small dense LDL (34), lipopro-
tein(a) (29), homocysteine (35), fibrinolytic and thrombo-
genenic risk factors like tissue plasminogen activator, plas-
minogen activator inhibitor and fibrinogen are associated
with CAD (13,36–38).
This study confirms that subjects with glucose intolerance
have a greater risk of CAD (Table 1). It is well known that
patients with type 2 diabetes have a twofold to threefold
increased risk of developing CAD (39). Recent findings
from the United Kingdom Prospective Diabetes Study
(UKPDS) (40) show that among type 2 diabetic subjects, a
quintet of potentially modifiable risk factors, namely in-
creased concentration of LDL cholesterol, decreased con-
centration of HDL cholesterol, hypertension, hyperglyce-
mia and smoking confer the risk of CAD.
Smoking, a well-established risk factor (41), had no
association with CAD in this study. However, earlier case
control studies have shown smoking to be a risk factor in
Indians (9). The absence of association with smoking in this
study can be attributed to small sample size or the under-
reporting of smoking due to cultural and other barriers.
Unfortunately, we could not perform serum nicotine esti-
mations to quantify smoking habits in this study.
Lipids and CAD. It is well known that Asian Indians have
low HDL cholesterol levels, which could be one of the risk
factors for premature CAD in this ethnic group (1,19). This
study confirms that the mean HDL cholesterol is low in our
population (1.03 mmol/l [40 mg/dl]). However, there was
no difference in mean HDL cholesterol levels between the
group with CAD and the group without CAD. Low-
density lipoprotein cholesterol levels were high in the CAD
group, although the actual LDL elevation was only modest.
It is possible that in the face of low HDL cholesterol, even
modest elevation of LDL with consequent elevation of the
LDL/HDL and total cholesterol/HDL cholesterol ratio
could contribute to atherogenesis in this population.
On univariate regression analyses, serum triglyceride had
an association with CAD. However, it was not significant
on multivariate analyses. Earlier reports in migrant Indians
had stressed the role of elevated serum triglycerides as a risk
factor for CAD in this ethnic group (42). However, the role
of serum triglycerides as a risk factor for CAD remains
controversial (43–45). A recent report generated from the
analyses of data from the Multiple Risk Factor Intervention
trial and three other trials concluded that triglyceride
measurements do not provide clinically meaningful infor-
mation about coronary heart disease risk beyond that
obtained by cholesterol measurements (46).
It is unlikely that use of lipid lowering drugs could have
affected the results of this study as only seven of the study
subjects were receiving any lipid-lowering drugs. This is
because of the high cost of these drugs, which restricts their
use in developing countries.
Study limitations. One of the limitations of this study is
that being a cross-sectional one, it represents only survivors
of MI. As CAD and diabetes both occur at a younger age,
Table 3. Multiple Logistic Regression of Determinants of CAD
Variables b S. E. p Value OR (95% CI)
Age 0.053 0.0119 , 0.0001 1.05 (1.03–1.08)
Body mass index 0.030 0.04 0.43 1.03 (1.0–1.1)
Systolic blood
pressure
20.0019 0.015 0.90 1.0 (0.97–1.03)
Diastolic blood
pressure
0.0126 0.022 0.57 1.01 (0.9–1.06)
Fasting plasma
glucose
0.004 0.003 0.87 1.004 (1.0–1.006)
HDL cholesterol 20.014 0.020 0.49 1.0 (0.95–1.03)
LDL cholesterol 0.0090 0.0046 0.051 1.009 (1.0–1.02)
Serum triglycerides 0.004 0.003 0.17 1.004 (1.0–1.09)
Dependent variable: coronary artery disease; independent continuous variables: age,
body mass index, systolic blood pressure, diastolic blood pressure, fasting plasma
glucose, HDL cholesterol, LDL cholesterol, serum triglycerides.
CAD 5 coronary artery disease; CI 5 confidence interval; HDL 5 high-density
lipoprotein; LDL 5 low-density lipoprotein; OR 5 odds ratio.
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many could have died at a young age due to CAD or other
complications of diabetes. The second limitation of the
study is that treatment with hypertensive drugs among the
CAD group could have resulted in lower BP, which could
be one of the reasons for the lack of association of BP with
CAD. Moreover, hypertension was assessed using a con-
ventional sphygmomanometer. This could have introduced
observer bias. However, as all readings were taken by the
same observer and two readings were taken and averaged,
we believe this would have reduced this bias to some extent.
Prospective longitudinal follow-up studies are required to
throw light on the true risk factors for various cardiovascular
end points including mortality. We intend to follow-up this
cohort to obtain such data in the future.
Conclusions. The prevalence of CAD among urban South
Indians is increasing rapidly and is now approaching the
figures reported in migrant Asian Indians. Urgent steps are
needed to modify lifestyle by increasing physical activity,
modifying diet and perhaps making aggressive use of statins
as part of the preventive strategy to reduce risk factors and,
thus, the burden of CAD in this population.
Acknowledgment
We thank Professor Srinath Reddy and Dr. D. Prabhaka-
ran, Department of Cardiology, the All India Institute of
Medical Sciences, New Delhi, India, for training Dr. G.
Premalatha in Minnesota coding of ECGs.
Reprint requests and correspondence: Dr. V. Mohan, Madras
Diabetes Research Foundation, 35 Conran Smith Road, Gopala-
puram, Chennai - 600 086 India. E-mail: mvdsc@vsnl.com.
REFERENCES
1. Enas EA, Garg A, Davidson MA, et al. Coronary heart disease and its
risk factors in first-generation immigrant Asian Indians to the United
States of America. Indian Heart J 1996;48:343–52.
2. Hughes K, Yeo PPB, Lun KC, et al. Ischaemic heart disease and its
risk factors in Singapore in comparison with other countries. Ann
Acad Med 1989;18:245–9.
3. Anand SS, Yusuf S, Vuksan V, et al. Differences in risk factors,
atherosclerosis, and cardiovascular disease between ethnic groups in
Canada: the Study of Health Assessment and Risk in Ethnic groups
(SHARE). Lancet 2000;356:279–84.
4. Balarajan R. Ethnic differences in mortality from ischemic heart
disease and cerebrovascular disease in England and Wales. BMJ
1991;302:560–4.
5. Reddy KS, Yusuf S. Emerging epidemic of CVD in the developing
countries. Circulation 1998;97:596–601.
6. Dhawan J. Coronary heart disease risks in Asian Indians. Curr Opin
Lipidol 1996;7:196–8.
7. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and
insulin resistance with high diabetes prevalence and cardiovascular risk
in South Asians. Lancet 1991;337:382–6.
8. Ramachandran A, Snehalatha C, Latha E, et al. Clustering of
cardiovascular risk factors in urban Asian Indians. Diabetes Care
1998;21:967–71.
9. Pais P, Pogue J, Gerstein H, et al. Risk factors for acute myocardial
infarction in Indians: a case-control study. Lancet 1996;348:358–63.
10. Gerstein HC, Pais P, Pogue J, Yusuf S. Relationship of glucose and
insulin levels to the risk of myocardial infarction: a case control study.
J Am Coll Cardiol 1999;33:612–9.
11. Rajadurai J, Arokiasamy J, Pasamanickam K, et al. Coronary artery
disease in Asians. Aust NZ J Med 1992;22:345–8.
12. Bhatnagar D, Anand IS, Durrington PN, et al. Coronary risk factors
in people from the Indian subcontinent living in West London and
their siblings in India. Lancet 1995;345:405–9.
13. Ramachandran A, Sathyamurthy I, Snehalatha C, et al. Risk variables
for coronary artery disease in Asian Indians. Am J Cardiol 2001;87:
267–71.
14. Shanthi Rani CS, Rema M, Deepa R, et al. The Chennai Urban
Population Study (CUPS): Methodological Details (CUPS paper no.
1). Int J Diab Dev Countries 1999;19:149–55.
15. Alberti KGMM, Zimmet PZ. Definition diagnosis and classification
of diabetes mellitus and its complications. Part 1: Diagnosis and
classification of diabetes mellitus: provisional report of a WHO
consultation. Diabetic Med 1998;15:539–53.
16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concen-
tration of low-density lipoprotein cholesterol in plasma without use of
the preparative ultracentrifuge. Clin Chem 1972;18:499–502.
17. Joint National Committee on Detection, Evaluation and Treatment of
High Blood Pressure. The fifth report of the Joint National Commit-
tee on Detection, Evaluation and Treatment of High Blood Pressure
(JNC-V). Arch Intern Med 1993;153:154–83.
18. McKeigue PM. Coronary heart disease in Indians, Pakistanis, and
Bangladeshis: aetiology and possibilities for prevention. Br Heart J
1992;67:341–2.
19. Beckles GL, Miller GJ, Kirkwood BR, Alexis SD, Carson DC. High
total and cardiovascular disease mortality in adults of Indian descent in
Trinidad, unexplained by major coronary risk factors. Lancet 1986;1:
1298–301.
20. Enas EA, Yusuf S, Mehta JL. Prevalence of coronary artery disease in
Asian Indians. Am J Cardiol 1992;70:945–9.
21. Shaukat N, de Bono DP. Are Indo-origin people especially susceptible
to coronary artery disease? Postgrad Med J 1994;70:315–8.
22. UK Prospective Diabetes Study Group. UK Prospective Diabetes
Study XII: differences between Asian, Afro-Caribbean and white
Caucasian type 2 diabetic patients at diagnosis of diabetes. Diabetic
Med 1994;11:670–7.
23. Padmavati S, Gupta S, Pantulu GVA. Dietary fats, serum cholesterol
levels and incidence of atherosclerosis in Delhi. Circulation 1959;19:
849.
24. Sarvotham SG, Berry JN. Prevalence of coronary artery disease in
urban population in northern India. Circulation 1968;37:939–53.
25. Raman Kutty V, Balakrishnan KG, Jayasree AK, Thomas J. Prevalence
of coronary heart disease in the rural population of Thiruvanantha-
puram district, Kerala, India. Int J Cardiol 1993;39:59–70.
26. Chadha SL, Radhakrishnan S, Ramachandran K, Kaul U, Gopinath
N. Epidemiological study of coronary heart disease in urban popula-
tion of Delhi, India. J Med Res 1990;92:424–30.
27. Gupta R, Prakash H, Majumdar S, Sharma S, Gupta VP. Prevalence
of coronary heart disease and coronary risk factors in urban population
of Rajasthan, India. Indian Heart J 1995;47:331–8.
28. Mohan V, Deepa R, Haranath SP, et al. Lipoprotein(a) is an
independent risk factor for coronary artery disease in NIDDM patients
in South India. Diabetes Care 1998;21:1819–23.
29. LaRosa JC, Hunninghake D, Brush D, et al. The cholesterol facts. A
summary of the evidence relating dietary fats, serum cholesterol and
coronary artery disease. A joint statement by the American Heart
Association and the National Heart, Lung and Blood Institute.
Circulation 1990;81:1721–33.
30. Careton RA, Dwyer J, Finberg L, et al. Report of the expert panel on
population strategies for blood cholesterol reduction. A statement
from the National Cholesterol Education Program. Circulation 1991;
83:2154–232.
31. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for
coronary artery disease independent of high density cholesterol level: a
meta-analysis of population-based prospective studies. J Cardiovasc
Risk 1996;3:213–9.
32. Davingnon J, Cohn JS. Triglycerides: a risk factor for coronary heart
disease. Atherosclerosis 1996;124:S57–64.
33. Yudkin JS, Forrest RD, Johnson CA. Microalbuminuria as a predictor
of vascular disease in nondiabetic subjects. Lancet 1988;2:530–3.
34. Kulkarni RK, Markovitz JH, Nanda NC, Segrest JP. Increased
prevalence of smaller and denser LDL particles in Asian Indians.
Atheroscler Thromb Vasc Biol 1999;19:2749–55.
686 Mohan et al. JACC Vol. 38, No. 3, 2001
CAD in South Indians September 2001:682–7
35. Chambers JC, Obeid OA, Refsum H, et al. Plasma homocysteine
concentrations and risk of coronary heart disease in UK Indian Asian
and European men. Lancet 2000;355:523.
36. Yudkin JS. Coronary heart disease in diabetes mellitus: three new risk
factors and a unifying hypothesis. J Int Med 1995;238:21–30.
37. Hamster A, Walldius G, Blomback M, et al. Plasminogen activator
inhibitor in plasma risk factor for recurrent myocardial infarction.
Lancet 1998;2:3–8.
38. Olofsson BO, Dhalen G, Nilsson TK. Evidence for increased levels of
plasminogen activator inhibitor and tissue plasminogen activator in
plasma of patients with angiographically verified coronary artery
disease. Eur Heart J 1989;10:77–82.
39. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality
from CAD in subjects with type 2 diabetes and in nondiabetic subjects
with and without prior myocardial infarction. N Engl J Med 1998;
339:229–34.
40. Turner RC, Millns H, Neil HAW, et al. Risk factors for coronary
artery disease in noninsulin dependent diabetes mellitus: United
Kingdom Prospective Diabetes Study (UKPDS:23). BMJ 1998;316:
823–8.
41. Arnett DK, Sprafka JM, McGovern PG, et al. Trends in cigarette
smoking: the Minnesota Heart survey, 1980 through 1992. Am J
Public Health 1998;88:1230–3.
42. McKeigue PM, Miller GJ, Marmot MG. Coronary artery disease
in South Asian overseas: a review. J Clin Epidemiol 1989;41:597–
608.
43. Jappensen J, Hein HO, Suadicani P, Gyntelberg F. Relation of high
TG-low HDL cholesterol and LDL cholesterol to the incidence of
ischaemic heart disease: an 8-year follow-up in the Copenhagen male
study. Arterioscler Thromb Vasc Biol 1997;17:1114–20.
44. Hulley SB, Rosenman RH, Bawol RD, Brand RJ. Epidemiology as a
guide to clinical decisions: the association between triglyceride and
coronary heart disease. N Engl J Med 1980;302:1383–9.
45. Ginsberg HN. Is hypertriglyceridemia a risk factor for atherosclerotic
cardiovascular disease? A simple question with a complicated answer.
Ann Intern Med 1997;126:912–4.
46. Avins AL, Neuhaus JM. Do triglycerides provide meaningful
information about heart disease risk? Ann Intern Med 2000;160:
1937– 44.
687JACC Vol. 38, No. 3, 2001 Mohan et al.
September 2001:682–7 CAD in South Indians
